binimetinib

Array wrestles FDA OK for its MEK/BRAF melanoma combo, to hit the pharmacy as Mektovi and Braftovi
Endpoints
Wed, 06/27/18 - 09:44 pm
Array Biopharma
binimetinib
Mektovi
Braftovi
melanoma
Encorafenib and Binimetinib Combination Results Show Improved Survival in BRAF-Mutant Advanced Melanoma Patient
CP Wire
Mon, 06/4/18 - 09:16 am
Array Biopharma
encorafenib
binimetinib
advanced melanoma
ASCO 2018
3 Biotechs With Huge FDA Decisions in June
Motley Fool
Thu, 05/31/18 - 10:00 pm
biotech
Array Biopharma
encorafenib
binimetinib
GW Pharma
Epidiolex
Incyte
olumiant
Array melanoma drugs show significant survival versus Roche drug in study
Reuters
Wed, 02/7/18 - 09:58 am
Array Biopharma
melanoma
Roche
encorafenib
binimetinib
Array Biopharma ties up with Pfizer on cancer-fighting combos
Fierce Biotech
Wed, 12/20/17 - 09:51 am
Array Biopharma
Pfizer
clinical trials
binimetinib
talazoparib
Merck KGaA
Bavencio
cancer
Why Array BioPharma Inc. Sank 13.5% in May
Motley Fool
Wed, 06/7/17 - 10:08 am
Array Biopharma
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
binimetinib
encorafenib
Array walks back its FDA pitch on binimetinib, derailing plans for commercial launch
Endpoints
Mon, 03/20/17 - 09:35 am
Array Biopharma
FDA
binimetinib
NRAS-positive melanoma
melanoma
3 Cancer Drugs That Could Get an FDA OK Next Year
Motley Fool
Mon, 10/10/16 - 09:02 am
FDA
rucaparib
Clovis Oncology
ovarian cancer
binimetinib
Array Biopharma
melanoma
brigatinib
Ariad Pharmaceuticals
non-small cell lung cancer
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
Wed, 09/14/16 - 11:53 pm
FDA
clinical trials
Array Biopharma
binimetinib
Mast Therapeutics
Novavax
RSV F vaccine
Threshold Pharmaceuticals
tarloxotinib
Cerulean Pharma
Vertex Pharmaceuticals
Orkambi
Exelixis
cabozantinib
Cobimetinib
Medivation
Xtandi
Celldex
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St
Sat, 09/3/16 - 12:17 pm
FDA
Achillion
odalasvir
AL-335
simeprevir
Amarin
Vascepa
Array Biopharma
binimetinib
Mast Therapeutics
vepoloxamer
Novavax
Threshold Pharmaceuticals
tarloxotinib
Array Bio ends late-stage study of ovarian cancer drug
Yahoo/Reuters
Fri, 04/1/16 - 10:16 am
Array Biopharma
clinical trials
ovarian cancer
binimetinib
Array Biopharma melanoma drug succeeds in late-stage study
Yahoo/Reuters
Wed, 12/16/15 - 10:09 am
Array Biopharma
melanoma
binimetinib
Array shares jump after drugmaker details Novartis deal
Yahoo/AP
Fri, 01/23/15 - 03:27 pm
Array Biopharma
Novartis
encorafenib
binimetinib
cancer
Array Biopharma Regains Rights to Cancer Drug From Novartis
TheStreet.com
Wed, 12/3/14 - 09:16 pm
Array Biopharma
Novartis
binimetinib
cancer
GSK